Cargando…
Determinants of Progression in Early Autosomal Dominant Polycystic Kidney Disease: Is it Blood Pressure or Renin-Angiotensin-Aldosterone-System Blockade?
BACKGROUND: The HALT PKD trial in early autosomal dominant polycystic kidney disease (ADPKD) showed that intensive control of systolic blood pressure to 95-110 mmHg was associated with a 14% slower rate of kidney volume growth compared to standard control. It is unclear whether this result was due t...
Autores principales: | Brosnahan, Godela M., Abebe, Kaleab Z., Moore, Charity G., Bae, Kyongtae T., Braun, William E., Chapman, Arlene B., Flessner, Michael F., Harris, Peter C., Hogan, Marie C., Perrone, Ronald D., Rahbari-Oskoui, Frederic F., Steinman, Theodore I., Torres, Vicente E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6063360/ https://www.ncbi.nlm.nih.gov/pubmed/29564978 http://dx.doi.org/10.2174/1573402114666180322110209 |
Ejemplares similares
-
Longitudinal Assessment of Left Ventricular Mass in Autosomal Dominant Polycystic Kidney Disease
por: Dad, Taimur, et al.
Publicado: (2018) -
Pain and Obesity in Autosomal Dominant Polycystic Kidney Disease: A Post Hoc Analysis of the Halt Progression of Polycystic Kidney Disease (HALT-PKD) Studies
por: Nowak, Kristen L., et al.
Publicado: (2021) -
Quest for the Cure: Testing the Old and New to Prevent Progression of Autosomal Dominant Polycystic Kidney Disease
por: Brosnahan, Godela
Publicado: (2019) -
Erythropoietin and Fibroblast Growth Factor 23 in Autosomal Dominant Polycystic Kidney Disease Patients
por: Hanudel, Mark R., et al.
Publicado: (2019) -
Management of proteinuria: blockade of the renin–angiotensin–aldosterone system
por: Athavale, Akshay, et al.
Publicado: (2020)